In multiple sclerosis (MS), lymphocyte-in particular B cell-transit between the central nervous system (CNS) and periphery may contribute to the maintenance of active disease. Clonally related B cells exist in the cerebrospinal fluid (CSF) and peripheral blood (PB) of MS patients; however, it remains unclear which subpopulations of the highly diverse peripheral B cell compartment share antigen specificity with intrathecal B cell repertoires and whether their antigen stimulation occurs on both sides of the blood-brain barrier. To address these questions, we combined flow cytometric sorting of PB B cell subsets with deep immune repertoire sequencing of CSF and PB B cells. Immunoglobulin (IgM and IgG) heavy chain variable (V H ) region repertoires of five PB B cell subsets from MS patients were compared with their CSF Ig-V H transcriptomes. In six of eight patients, we identified peripheral CD27 
INTRODUCTION
Fuelled by recent advances in multiple sclerosis (MS) therapy using CD20-targeted B cell depletion (1-3), efforts to further understand features of disease-relevant (pathogenic) B cell autoimmunity have increased, both in MS patients and in animal models of MS. Clonal overlap between B cell receptor (BCR) sequences in MS brain parenchyma, meningeal lymphoid follicles, and cerebrospinal fluid (CSF) indicates an immunological continuum inside the central nervous system (CNS) (4, 5) . Furthermore, we have previously shown that antigendriven B cell immune responses inside the CNS compartment are not sequestered from peripheral B cell responses (6) , suggesting that disease-driving immune mechanisms against, as yet unknown, identical or highly similar antigenic epitopes operate in the CNS and periphery. Together, these data establish that antigen-experienced B cells provide an immunological connection between numerous different tissues where they may either directly or indirectly support CNS-targeting autoimmunity. The ability to specifically identify and potentially target pathogenic B cells in autoimmune conditions like MS may provide an important basis for the development of immune therapies with improved efficacy and long-term safety. On the basis of previous studies, including our own, it is generally assumed that antigen-experienced B cell subsets provide a pathologically relevant link between the CNS and periphery. However, to date, there is a complete lack of knowledge regarding which subsets of the highly diverse and complex peripheral B cell compartment support CNS-directed autoimmunity.
We applied multicolor flow cytometry sorting of peripheral blood (PB) B cell subsets in combination with next-generation deep immunoglobulin (Ig) heavy chain variable region (Ig-V H ) repertoire sequencing (DIRS) of PB B cells and CSF lymphocytes to identify and characterize disease-associated peripheral B cell subsets. We found clusters of clonally related B cells involving CSF-derived Ig-V H and PB CD27 
RESULTS

Sequencing output
We examined the Ig repertoires in CSF and five different PB B cell subsets ( Fig. 1 ) of eight individual patients with clinically definitive MS ( Table 1) . Seven of eight patients had more than five oligoclonal bands (OCBs) in their CSF and an increased IgG index (Table 1 ). All patients were untreated and displayed MS-typical changes on magnetic resonance imaging (MRI) ( Table 1) . One patient (14711) had active disease at the time of lumbar puncture (LP) (fig. S1); all others had either clinically stable or quiescent relapsing-remitting MS or primary progressive MS without recent contrast enhancement on gadoliniumenhanced MRI (Table 1 ). The distribution of sorted PB B cells used as input varied across subsets and patients (table S1). CSF IgG-V H sequences were obtained from all patients; CSF IgM-V H transcripts were sequenced for four patients (31012, 34012, 43113, and 43213). From PB of all patients, either IgM-V H or IgM-V H /IgG-V H transcripts were obtained from the following sorted subpopulations: naïve B cells, CD19 (Fig. 1 ). Each sample was subjected to unbiased 5′-RACE [rapid amplification of complementary DNA (cDNA) ends] and DIRS; separation into IgG-V H -and IgM-V H -expressing B cell subsets was achieved by using isotype-specific (IgM and IgG) reverse primers during Ig-V H 5′-RACE. Because of the generally low numbers of lymphocytes in CSF, we chose to directly perform IgM-V H and IgG-V H 5′-RACE from each CSF cell pellet without sorting of B cell subsets. We obtained a total of ∼2.2 million sequencing reads, resulting in ∼1.3 million usable IgM-V H or IgG-V H transcripts (table S1). Sequencing reads were deposited at the National Center for Biotechnology Information (NCBI) Sequencing Read Archive (SRA; http://www.ncbi.nlm.nih.gov/Traces/sra/) under accession number SRP042205. Two sequence-clustering approaches were applied for Ig-V H analyses. (i) A distance metric approach [Hamming distance = 1 (7)] was used to group clonally related Ig-V H with highly similar H-CDR3 amino acid sequence, identical H-CDR3 length, and usage of the same IGHV and IGHJ. Clonally related Ig-V H sequences were used to identify and analyze bicompartmental B cell clusters as previously described (6) . (ii) Ig-V H data sets of nonredundant Ig-V H reads were generated by considering sequences with identical H-CDR3 and usage of IGHV and IGHJ only once; nonredundant data sets were used to calculate IGHV usage as previously described (6, 8, 9) and to generate somatic hypermutation (SHM) profiles. An overview of the bioinformatics pipeline used for our studies is shown in fig. S2 . Among B cell subsets, the numbers of redundant Ig-V H associated with each nonredundant Ig-V H sequence revealed overall mostly low counts for naïve B cell IgM-V H (N.IgM) and partially very high counts of sequences with identical H-CDR3, IGHV, and IGHJ usage not only in post-GC, Ig class-switched B cells but also in CSF Ig-V H repertoires ( fig. S3) . Thus, to a reasonable degree, our sequencing approach approximated what is expected biologically: absent clonal expansion among naïve B cells, and extensive clonal activation in B cell subsets resulting from antigen-driven immune responses, such as switched memory B cells and plasmablasts/plasma cells. In addition, this finding supported previous reports of B cell activation in the CNS and CSF (10) (11) (12) (13) (14) .
Here, we used polymerase chain reaction (PCR) amplification of Ig-V H and next-generation immune repertoire sequencing (DIRS). In general, overamplification or sequencing saturation of particularly prevalent Ig-V H transcripts could introduce skewing of data and affect conclusions drawn, particularly with regard to estimating clonal B cell stimulation. Furthermore, in next-generation sequencing, sequencing errors are a potential concern, particularly with respect to DIRS, where read errors could be mistaken for evidence of SHM (15, 16) . In the following paragraphs, we will discuss the potential impact of these issues on our results and interpretations where applicable.
Bicompartmental B cell clusters
We identified a total of 46 bicompartmental clusters of clonally related Ig-V H in six of eight patients (14711, n = 15 clusters; 30512, n = 1; 31012, n = 7; 34012, n = 7; 43113, n = 13; 43213, n = 3) (Fig. 1, fig. S4 , Table 2 , and tables S2 and S3) on the basis of H-CDR3 amino acid sequence similarity and usage of Ig germline segments, features that readily discern Ig-V H sequences of a common origin (17, 18) . In all six patients with bicompartmental B cell clusters, we identified CSF IgG-V H clusters connecting to PB IgG + switched memory B cells (n = 35 clusters). In all four patients from which CSF IgM-V H transcripts were sequenced, we found clusters that were composed of CSF IgM-V H and IgM-expressing switched memory B cells from PB (n = 5 clusters). In three patients, seven CSF IgG-V H clusters connected to PB IgG + plasma cell clusters, two of which interconnected with IgG + switched memory B cells (Table 2 and table S2 (Table 2 and table S2) . No bicompartmental clusters were found in a patient without OCB (29612) and in one other patient, the oldest patient in our cohort (26712, 54-year-old female). It is noteworthy that, for these two patients, no CSF IgM-V H sequences were obtained; it is thus possible that a connection between IgM-expressing PB B cell subsets and the CSF did exist but was not identified for technical reasons. Notably, no connections were identified between CSF and naïve or unswitched memory B cells in PB. In linear regression analyses, the numbers of bicompartmental IgG-V H clusters obtained did not correlate with CSF white blood cells (WBCs) (r 2 = 0.39, P = 0.1) or CSF volume (ranging from 5 to 20 ml) (r 2 = 0.12, P = 0.4), suggesting that detection of B cell clusters connecting the CSF and periphery does not depend on either factor (table  S4) . Similarly, the numbers of bicompartmental IgG-V H were also independent from IgG index (r 2 = 0.46, P = 0.07) or total CSF IgG-V H reads (r 2 = 0.12, P = 0.4) (table S4). Bicompartmental clusters generally comprised less than 1% of PB B cell subset clusters ( fig. S4 and  table S5 ). An exception were bicompartmental clusters involving plasma cells/plasmablasts in patient 14711 comprising nearly 5% of Ig-V H clusters, which may be due to the overall low number of plasma cells/ plasmablasts sorted from this patient, but it may also suggest active egress of antibody-producing cells from the CSF (tables S1 and S5).
Affinity maturation in the CNS and periphery
We were interested to determine whether B cells belonging to bicompartmental clusters undergo affinity maturation in the periphery and/or the CNS compartment. Numerous IgM-V H and IgG-V H from either compartment contain multiple SHM along their IGHVderived portion ( Table 2 ), suggesting that they resulted from antigendriven immune responses. From our data, it is not possible to draw conclusions whether a B cell response originated in one or the other compartment; however, within clusters of related Ig-V H , we commonly identified a range of SHM ( Fig. 2 and Table 2) in the periphery and/or CSF, suggesting that B cells belonging to bicompartmental clusters may have been exposed to antigen stimulation in either compartment.
Sequencing errors cannot be fully differentiated from true SHM when sequencing natural Ig-V H repertoires where the mRNA templates are not known. In the analyses of our sequencing data, we applied a reductionist approach to only use high-quality Ig-V H sequences for our conclusions regarding SHM occurring in CSF and/or periphery (see Materials and Methods and fig. S2 ). In 454 sequencing, the probability of sequencing errors due to single and multiple substitutions is less than 10% based on previous quantification (15) . Because most nodes in our lineage analysis contain at least two identical in-frame sequencing reads, the probability of one single SHM due to substitution errors is less than 0.01 for a particular node containing two identical sequences [type I error rate less than 1% (15)]; with each additional identical sequencing read contained in a tree node, the probability of sequencing errors is reduced by a factor of 0.1. Accordingly, for three identical sequences to represent a sequencing error, the probability is <0.001, for four sequences <0.0001, for five sequences <0.00001, etc. Thus, lineage relationships of Ig-V H generated by our sequencing approach and calculated using IgTree software (19, 20) IGHV usage in Ig-V H repertoires in PB and CSF Although our primary focus was to characterize B cells providing an immune axis between CNS and PB, our data also enabled Ig germline gene usage analyses in the overall CSF and PB B cell subset Ig repertoires obtained by DIRS. We found diverse IGHV usage among most PB B cell subsets ( Fig. 3 and table S6 ). Overall, IGHV usage in CSF was limited compared to PB B cells (Fig. 3 ), whereas IGHV usage by different B cell subsets was generally similar within individual patients. Patient 14711 who had active CNS inflammation with gadolinium contrast-enhancing cervical spinal cord lesions on MRI 2 weeks before LP (Table 1 and fig. S1 ) displayed more diverse IGHV usage in CSF compared to all other patients ( fig. S6 ). Previous studies, including our own, have shown overrepresentation of certain IGHV4 germline segments in MS CSF (6, 10, 21, 22) ; in the present study, IGHV4-39 was used by CSF IgG-V H in seven of eight patients, and IGHV4-59/61 by six of eight patients' CSF IgG-V H (Fig. 3) . Possibly artifactual limited IGHV usage was seen in PB B cell subsets for which low cell numbers were obtained by cell sorting, or when fewer nonredundant Ig-V H sequences were available; examples are 26712 double negative IgM, 30512 plasma cell/plasmablast IgM, and 30512 plasma cell/plasmablast IgG (table S1 and Fig. 3 ).
Biased IGHV usage representation could result from overamplification of certain Ig-V H transcripts during PCR or saturation of the sequencing reaction by overrepresented Ig-V H . For our studies, we used 5′-RACE of Ig-V H to eliminate potential biased introduced by IGHVspecific primers and used nonredundant Ig-V H sequence counts to (Fig. 4A) . IgG-expressing double negative B cells clustered with IgMexpressing B cell subsets including unswitched memory, switched memory, and plasma cells/plasmablasts (Fig. 4E) , overall suggesting lower levels of SHM having shaped the double negative B cell repertoire. Within B cell subsets, IgG-V H had accumulated more SHM compared to IgM-V H (Fig. 4) . SHM profiles of CSF IgG-V H appeared most similar to IgGexpressing switched memory and plasma cells/plasmablasts (Fig. 4B) , whereas SHM profiles of CSF IgM-V H appeared more similar to IgM-expressing naïve, unswitched memory, and double negative B cell subsets (Fig. 4) .
Overall, the SHM patterns displayed in Fig. 4 support the validity of the B cell subset sorting approach based on CD19, CD27, CD38, and IgD, together with IgM-and IgG-specific PCR amplification of V H . Furthermore, the observed SHM profiles, that is, very low levels of SHM in naïve B cells and the most extensive SHM in IgG-expressing switched memory B cells and antibody-producing plasma cells/plasmablasts (Fig. 4) , further suggest that our sequencing approach yielded biologically correct data. The antigens targeted by B cells participating in the immune axis between periphery and CNS remain unknown. It was previously shown that clonally expanded intrathecal plasma cells produce antibodies that bind to as yet unknown myelin or myelin-associated antigens in demyelinating lesions of MS (13) , and soluble IgG binding to myelin-oligodendrocyte protein was identified in MS CSF (23, 24) . Accordingly, bicompartmental B cell clusters are assumed to participate in potentially CNS-reactive B cell responses. Still, clonal CSF IgG has also been shown to react with Epstein-Barr virus antigens (25) , at least raising the possibility that bicompartmental B cell clusters target viral or (table S6) . To generate heatmaps, IGHV usage values were normalized to the most frequently used IGHV per sample and Ig isotype, which were set as 1. The resulting heatmaps show the most frequently used IGHV in white and the least frequently used IGHV in dark blue (see lower left corner for scale). Notably, IGHV usage is generally limited in CSF (red type), suggesting selective recruitment or survival of B cells in the CSF compartment. IGHV usage of CSF IgG-V H in patient 14711 is more balanced and similar to peripheral B cell repertoires; this patient had signs of active disease 2 weeks before LP (Table 1) . microbial epitopes and possibly cross-react with CNS epitopes via molecular mimicry, as was shown for T cells in MS (26) . Considering that in humans a multitude of viruses are constantly replicating (27) , which could stimulate both CNS-specific and nonspecific B cell responses via bystander activation, significant additional work is necessary to understand the involvement of bicompartmental B cell clusters in MS disease activity.
In our study, class-switched memory B cells were found most frequently to provide an immune axis between PB and CSF. Memory B cells are strongly CD20-positive and are efficient antigen-presenting cells (28, 29) ; memory B cells reactive against myelin have been shown to be present in MS patients' blood (30) . CD20-targeting, B cell-depleting monoclonal antibodies (rituximab and ocrelizumab) are highly effective in reducing or eliminating MS disease activity (1-3), and in depleting B cells from CSF (31) . Our finding that memory B cells participate in an exchange across the blood-brain barrier (BBB) further strengthens the rationale of using anti-CD20-mediated B cell depletion to interrupt disease-promoting peripheral B cell autoimmunity. Natalizumab, a monoclonal anti-VLA4 antibody that also effectively reduces MS disease activity, inhibits transmigration of lymphocytes from PB into the CNS compartment and reduces CSF B cell numbers (32) . Two studies described decreased intrathecal production of clonal Ig with natalizumab therapy (33, 34) , an effect that could be due to limiting transmigration of B cells involved in OCB production. However, natalizumab was also shown to reduce CSF CD4 + and CD8 + T cells and CD19 + B cells in MS patients (32) . Accordingly, intrathecal OCB production may require influx of B cells or T cells to provide signals for B cell differentiation into antibody-expressing plasma cells or plasmablasts, or a combination of both.
Intrathecal plasma cells and B cells are responsible for local production of clonal IgG (35, 36) . We found a few instances in three patients of PB plasma cells forming bicompartmental clusters with CSF IgG-V H , which is in agreement with our recent finding that antibodies identical to OCB can theoretically also be produced in the periphery (37 restricted peripheral plasma cells entering the CNS compartment is responsible for intrathecal antibody production, because this would require specific recruitment of select plasma cell clones into the CNS. More likely, plasma cells that participate in bicompartmental clusters are progeny of antigen-experienced memory B cells that became established in both the CNS and periphery. An important question that remains is whether the initial antigen exposure of naïve B cells that ultimately mature to bicompartmental memory B cells and OCB-producing plasma cells occurs in the periphery or CNS. Mature naïve B cells that migrate across the BBB could provide input into presumed GC in lymphoid follicle-like structures in the CNS (38, 39) . Consistent with this concept, IgD + CD27
− naïve B cells have been found in the CSF of MS patients (40) and evidence for B cell differentiation was found in MS CNS (41) . In further support of the presence of naïve B cells in CSF, we found CSF IgM-V H harboring very few mutations, suggesting an intrathecal presence of IgM-expressing B cells that have not yet undergone affinity maturation. However, the absence of IGHV usage diversity among CSF IgM-V H in the four patients from which CSF IgM-V H were obtained argues against an ongoing unrestricted exchange of naïve B cells in MS.
We found diverse IGHV usage in patient 14711 CSF, a possible example for a more balanced exchange of B cells during active MS, as previously reported in another MS patient with active disease (6) . We also found the largest number of bicompartmental Ig-V H clusters in this patient, but not all IGHV found in this patient's CSF are also represented in clonally related B cell clusters spanning periphery and CSF. Although speculative, it is possible that the observed clusters represent the pathologically relevant ones participating in active inflammation, whereas B cells expressing IGHV not represented by bicompartmental clusters are pathologically irrelevant. In all other patients' CSFs, we found limited IGHV usage, suggesting selective survival of B cells in the CNS compartment during disease states that appear quiescent by clinical or MRI measures.
In four of eight patients studied here, we found Ig class-switched double negative B cells that were clonally related to intrathecal Ig repertoires. As previously described by others (42, 43) , SHM profiles of double negative IgG-V H are frequently shifted toward fewer somatic mutations when compared to IgG + switched memory B cells, which may support double negative cells as progenitors of switched memory B cells. However, on the basis of a high-throughput immune repertoire sequencing study comparing Ig-V H of switched memory and double negative B cells, Ig class-switched CD27 − and CD27 + B cells may also be developmentally related in either direction, that is, with double negative B cells being precursors of switched memory B cells and vice versa (44) . PB double negative B cells are expanded in patients with active systemic lupus erythematosus; these cells have been proposed to represent a class of memory B cells that fail to undergo productive GC maturation (42) . B cells accumulating SHM outside of GCs likely also escape the scrutiny of peripheral B cell tolerance and may harbor increased autoimmune potential (45) . Our observation in this cohort of MS patients, that SHM profiles of IgMexpressing double negative B cells compare more closely to naïve B cells than unswitched memory B cells, suggests that they are direct progeny of naïve B cells and undergo class switch recombination (CSR) outside of GCs or exit GCs prematurely. Double negative B cells proliferate more readily upon Toll-like receptor-mediated activation than with BCR cross-linking, suggesting that they function in an antigenindependent manner (42) . Further work will be necessary to understand the relevance of double negative B cells to MS; however, our findings suggest that double negative B cells may be a relevant part of the immune axis linking the periphery with the CNS.
The identification of PB B cell subsets participating in bicompartmental immune response would not have been possible without highthroughput next-generation sequencing techniques that are far more comprehensive than Sanger sequencing-based approaches. Nonetheless, there are several limitations of our approach that should be recognized.
(i) We are unable to directly measure clonal expansion. However, the number of redundant Ig-V H associated with nonredundant reads appears to approximate biologically expected findings. With the technology used here, it is difficult to determine whether a given sequence appears more frequently because of a large quantity of its mRNA being recovered from a single cell or multiple cells expressing that same sequence, or because of disproportional PCR amplification or sequencing of certain Ig-V H transcripts. Higher number of reads per nonredundant Ig-V H could also reflect low sequence diversity within these populations and thus sequencing oversaturation. New technologies incorporating nucleotide tags (46, 47) or high-throughput singlecell sequencing technologies (48) (iii) Sequencing errors introduced by 454 sequencing could result in artifactual clonal families of Ig-V H sequences (16) . In our experiments, we studied natural Ig-V H repertoires without knowledge of template sequences. It is thus impossible for us to determine exactly which mutations are sequencing errors and which result from SHM. We applied a reductionist approach to select Ig-V H sequences for lineage analyses that incorporate likely true SHM, rather than sequencing errors. SHM profiles resulting from PB B cell subsets reveal biologically expected information (that is, low SHM in naïve B cells and extensive SHM in IgG-expressing memory B cells and plasma cells) and therefore suggest that, overall, sequencing errors do not exert extensive influence on the representation of SHM.
Despite these limitations, our data in summary reveal a highly dynamic and interconnected B cell repertoire shaping the PB and CNS immune landscape in MS. Our study represents an important initial snapshot of processes that are likely to come into better resolution as additional observations-especially those accompanying the early phases of disease development, during clinical attacks, and with transition to the late progressive phase of MS-are revealed. Indirectly, our findings suggest that exchange of disease-associated B cell subsets between the CNS and periphery in MS is a highly selective process. This process may be supported by B cells that have undergone CSR and/or affinity maturation, in the periphery and/or CNS compartment. Although the target antigens and exact mechanisms driving the establishment of intrathecal B cell repertoires remain unknown, the ability to identify antigen-experienced B cells participating in MS immune pathology, as described here, should help to resolve these key issues. In particular, identifying the specificity of bicompartmental B cells will ultimately link B cell exchange between periphery and CNS to MS immune pathology.
MATERIALS AND METHODS
Patient samples
We studied eight patients with clinically definitive MS (Table 1) based on the latest diagnostic criteria for MS (50) . Patients were selected on the basis of availability of paired CSF and sufficient PB. On the basis of a previous study (6) , we expected to identify bicompartmental clusters in about 80% of patients. No sample size calculations were performed before our experiments; data analyses were not performed blinded because no comparisons between different groups of patients were performed. PB (48 ml) was obtained via standard venipuncture; 5 to 20 ml of CSF were collected during standard LP during the same visit. To avoid potential CSF contamination with PB, the first 2 ml of CSF was discarded. Immediately after LP, the entire volumes of CSFs were centrifuged at 400g for 15 min, and cell pellets were lysed in RLT buffer (Qiagen RNeasy kit). PBMCs were isolated using a Ficoll gradient, red blood cells were lysed, and PBMCs were washed in phosphatebuffered saline (PBS) containing 1% bovine serum albumin (BSA). These studies were approved by the institutional review board of the University of California, San Francisco, and informed consent was obtained from patients before CSF/PB collection. (Fig. 1) . Gating controls (single-color histograms) for CD19, CD20, CD27, CD38, and IgD are shown in fig. S7 . Dead cells and T cells were gated out using DAPI and CD3 expression, respectively. B cell subsets were sorted and immediately lysed in RLT buffer (Qiagen RNeasy kit) and stored at −80°C.
Unbiased Ig mRNA amplification and Ig repertoire sequencing Sequencing work flow was performed as previously described (8) . In brief, total RNA was isolated from CSF (miRNeasy Mini Kit, Qiagen) and PB B cell subsets (RNeasy micro kit, Qiagen). RNA quality was assessed using an Agilent Bioanalyzer. Total isolated RNA was reverse-transcribed (SMARTer RACE, Clontech), and about 27% of each cDNA reaction was used for IgM-V H and IgG-V H amplification via PCR using SMARTer RACE 10× Universal Primer Mix (Clontech) and IgG or IgM isotypespecific 3′ primers (IgG, 5′-GGGAAGACSGATGGGCCCTTGGTGG-3′; IgM, 5′-GATGGAGTCGGGAAGGAAGTCCTGTGCGAG-3′) for 31 cycles following the manufacturer's recommendation. These primer sequences were attached to Lib-L-specific adaptor (454 sequencing, Roche) and barcode sequences to amplify IgG-V H and IgM-V H libraries. Barcoded IgM-V H [∼715 base pairs (bp)] and IgG-V H (∼640 bp) transcript libraries were purified using AMPure XP (Beckman Coulter Inc.), quantified using PicoGreen (Life Technologies), and normalized to 1 × 10 9 molecules/ml. Sequencing library pools of uniquely barcoded B cell subsets from each subject were created by pooling the normalized IgM-V H and IgG-V H amplified libraries at relative proportions to obtain 1× (double negative and plasma cells/plasmablasts), 2× (naïve), and 4× (switched memory and unswitched memory) sequencing depth, respectively. The final multiplexed library pools were subjected to emulsion PCR and unidirectional sequencing using the GS FLX Titanium Lib-L chemistry (454 Sequencing, Roche). Figure S2 illustrates and summarizes the bioinformatics pipeline used for Ig-V H sequence analysis. For all reads, IGHV and IGHJ gene segment usage, CDR1-3 amino acid sequence, and number of SHM events were determined using VDJFasta as previously described (9) . In general, Ig-V H sequences were considered related on the basis of the fact that IGHV and IGHJ usage are stable features of clonally related B cells, that H-CDR3 sequence is identical or highly similar between clonally related B cell, and that the H-CDR3 sequence length is virtually invariable within groups of clonally related B cells. For calculations of IGHV usage frequency, nonredundant Ig-V H sequence counts were considered; that is, sequences with identical H-CDR3, IGHV, and IGHJ were counted only once. The numbers of nonredundant IgG/M-V H are shown in table S1; per IGHV germline segment usage is displayed as percentage of all Ig-V H sequences obtained per sample. To generate SHM profiles, the most frequent SHM count encountered in a group of nonredundant Ig-V H was used. This approach ensured correction for potential overamplification of more abundant Ig-V H mRNAs.
Sequence analysis
To identify bicompartmental clusters containing IgM-V H or IgG-V H from CSF and PB B cell subsets, clonally related Ig-V H sequences were grouped on the basis of H-CDR3 similarity and usage of identical Ig germline segments. This approach combined Ig-V H containing identical H-CDR3 amino acid sequences and Ig-V H with H-CDR3 differing by a single amino acid compared to all other H-CDR3 in a cluster based on a Hamming distance = 1 (6, 7). For lineage analysis, only Ig-V H sequences for which in-frame H-CDR3 were identified and that spanned at least from the 5′ end of H-CDR1 to the 3′ end of H-CDR3 with a contiguous reading frame were considered; all out-of-frame sequences were thus automatically filtered on the basis of the presence of uncommonly occurring insertions and deletions (indels). Putative germline sequences were obtained using SoDA (34) and were used as tree root nodes (black) in our lineage tree calculations.
We used IgTree (19, 20) (provided by R. Mehr, Bar-Ilan University, Ramat-Gan, Israel) to calculate B cell lineages contained within each IgG-V H cluster. This software has been successfully used with DIRS data (20) . Automated multiple alignments of cluster-derived Ig-V H sequences and the corresponding germline sequence were performed using ClustalW 2.1 (51) . Lineage trees were displayed in Cytoscape [version 2.8.3 (52) ] using the proprietary organic layout, which permits a more compact depiction of lineages; tree nodes were colored according to their origin (CSF and PB cell subsets) and isotype (IgM and IgG).
Putative germline nodes are labeled black, and lineage intermediates not found by DIRS were calculated by IgTree and are labeled gray. The size of tree nodes is proportional to the number of identical sequences contained within each node. Ig-V H amino acid alignments were generated using the MAFFT algorithm (53) within Jalview (54) software.
Statistics
Linear regression analyses and analysis of variance (ANOVA) were performed in GraphPad Prism 6.0. Comparisons of numbers of reads in each nonredundant Ig-V H sequence group between naïve PB B cells and all other B cell subsets and CSF per patient (table S7) Table S1 . Sorted cells and sequence counts. Table S2 . PB B cell clusters connecting to the CSF/CNS compartment. Table S3 . Number of bicompartmental clusters by patient and B cell subset expressing Ig-V H related to CSF Ig-V H . Table S4 . Correlations between number of bicompartmental clusters found and CSF metrics. Table S5 . Bicompartmental clusters in proportion to total PB B cell clusters of the indicated PB B cell subset. Table S6 . IGHV usage data used to generate heatmaps displayed in Fig. 3 (separate Excel file). Table S7 . Comparisons of numbers of reads in each nonredundant Ig-V H sequence group between naïve PB B cells and all other B cell subsets and CSF per patient. Table S8 . SHM data used to generate heatmaps displayed in Fig. 4 (separate Excel file).
